Package 0054-0177-13

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 0054-0177-13
Digits Only 0054017713
Product NDC 0054-0177
Description

30 TABLET in 1 BOTTLE (0054-0177-13)

Marketing

Marketing Status
Marketed Since 2009-10-08
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "9c6bccc7-562f-4dc1-9076-b482570bee70", "openfda": {"upc": ["0300540176136"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["1bf8b35a-b769-465c-a2f8-099868dfcd2f"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0054-0177-13)", "package_ndc": "0054-0177-13", "marketing_start_date": "20091008"}], "brand_name": "Buprenorphine", "product_id": "0054-0177_9c6bccc7-562f-4dc1-9076-b482570bee70", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0054-0177", "dea_schedule": "CIII", "generic_name": "Buprenorphine", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA078633", "marketing_category": "ANDA", "marketing_start_date": "20091008", "listing_expiration_date": "20271231"}